This photo provided Oct. 9, 2012, by the Minnesota Department of Health shows shows vials of the injectable steroid product made by New England Compounding Center implicated in a fungal meningitis outbreak that were being shipped to the Centers for Disease Control and Prevention in Atlanta from Minneapolis. About 17,700 single-dose vials of the steroid sent to 23 states have been recalled. The outbreak involves 10 states, including Minnesota. (AP Photo/Minnesota Department of Health)
NASHVILLE, Tenn. (AP) -- Members of the Tennessee Board of Pharmacists will be discussing additional measures the state could take in regulating compounding pharmacies in the wake of a multistate outbreak of fungal meningitis that has sickened hundreds of people across the country.
Doctors in Tennessee were among the first to link the outbreak to steroid injections prepared by a Massachusetts compounding pharmacy. Across the county, 45 people, including 14 in Tennessee, have died after getting the shots.
A task force formed by the state board to look at state laws in regard to compounding pharmacies is expected to make recommendations during a meeting on Thursday morning.